Diego Dal Ben

Author PubWeight™ 14.12‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Toward the rational design of protein kinase casein kinase-2 inhibitors. Pharmacol Ther 2002 1.15
2 Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17. Purinergic Signal 2011 0.90
3 N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor. J Med Chem 2007 0.89
4 Synthesis and biological evaluation of 2-alkynyl-N6-methyl-5'-N-methylcarboxamidoadenosine derivatives as potent and highly selective agonists for the human adenosine A3 receptor. J Med Chem 2009 0.89
5 8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands. Bioorg Med Chem 2009 0.87
6 Amide bond direction modulates G-quadruplex recognition and telomerase inhibition by 2,6 and 2,7 bis-substituted anthracenedione derivatives. Bioorg Med Chem 2007 0.86
7 Highlights on the development of A(2A) adenosine receptor agonists and antagonists. ChemMedChem 2007 0.81
8 Comparison and optimization of transient transfection methods at human astrocytoma cell line 1321N1. Anal Biochem 2011 0.80
9 Evidence for the existence of a specific g protein-coupled receptor activated by guanosine. ChemMedChem 2011 0.79
10 Medicinal chemistry of P2X receptors: agonists and orthosteric antagonists. Curr Med Chem 2015 0.79
11 Adenine-based acyclic nucleotides as novel P2X3 receptor ligands. J Med Chem 2009 0.78
12 Novel potent and highly selective human A(3) adenosine receptor antagonists belonging to the 4-amido-2-arylpyrazolo[3,4-c]quinoline series: molecular docking analysis and pharmacological studies. Bioorg Med Chem 2008 0.77
13 Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists. Bioorg Med Chem 2011 0.77
14 Interaction model for anthracycline activity against DNA topoisomerase II. Biochemistry 2004 0.77
15 Adenosine A2A receptor antagonists: new 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson's disease. ChemMedChem 2009 0.77
16 Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists. Eur J Med Chem 2013 0.76
17 New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile. Purinergic Signal 2007 0.75
18 Synthesis and antitumor evaluation of bis aza-anthracene-9,10-diones and bis aza-anthrapyrazole-6-ones. J Med Chem 2008 0.75
19 Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists: synthesis, structure-affinity relationships and molecular modeling studies. Bioorg Med Chem 2012 0.75
20 Overview on Radiolabel-Free in vitro Assays for GPCRs. Mini Rev Med Chem 2017 0.75
21 Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs. Bioorg Med Chem 2008 0.75
22 Identification of alpha1-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferens. Eur J Pharmacol 2008 0.75
23 Pharmacological postconditioning of the rabbit heart with non-selective, A1 , A2A and A3 adenosine receptor agonists. J Pharm Pharmacol 2014 0.75
24 Synthesis and biological activity of trisubstituted adenines as A 2A adenosine receptor antagonists. Nucleosides Nucleotides Nucleic Acids 2007 0.75
25 Synthesis and stability studies of 2',3',5'-tri-O-acetyl-2-amino(-N6-cyclopentyl)-1-deazaadenosines. Nucleosides Nucleotides Nucleic Acids 2007 0.75